Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene-modified mouse expressing human GPC3 polypeptide

Gene-modified mouse expressing human GPC3 polypeptide

US Patent 11793180 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cytotoxicity-inducing therapeutic agent2025
Cytotoxicity-inducing therapeutic agent2025
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 an2023
Cytotoxicity-inducing therapeutic agent2023
Non-human animal having human CD3 gene substituted for endogenous CD3 gene2023
Non-human animal having human CD3 gene substituted for endogenous CD3 gene2023
Non-human animal having human CD3 gene substituted for endogenous CD3 gene2023
T cell-redirected antigen-binding molecule for cells having immunosuppression fu2022
Cell injury inducing therapeutic drug for use in cancer therapy2021
Cell injury inducing therapeutic drug for use in cancer therapy2021
Cytotoxicity-inducing therapeutic agent2021
Urokinase-type plasminogen activator transgenic mouse2021